» Articles » PMID: 36846536

Antiemetic Efficacy of Palonosetron Compared with the Combination of Ondansetron and Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Gynaecological Surgery

Overview
Publisher Sciendo
Specialty Anesthesiology
Date 2023 Feb 27
PMID 36846536
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: For the prevention of PONV, we evaluated the efficacy of palonosetron compared with ondansetron along with dexamethasone in patients undergoing laparoscopic gynaecological surgery.

Methods: A total of 84 adults, posted for elective laparoscopic surgeries under general anaesthesia were included in the study. The patients were randomly allocated to two groups (n = 42 each). Immediately after induction, patients in the first group (group I) received 4 mg ondansetron with 8 mg dexamethasone, and patients in the second group (group II) received 0.075 mg palonosetron. Any incidences of nausea and/or vomiting, the requirement of rescue antiemetic, and side effects were recorded.

Results: In group I, 66.67% of the patients had an Apfel score of 2, and 33.33% of the patients had a score of 3. In group II, 85.71% of patients had an Apfel score of 2, and 14.29% of the patients had a score of 3. At 1, 4, and 8 hours, the incidence of PONV was comparable in both groups. At 24 hours there was a significant difference in the incidence of PONV in the group treated with ondansetron with dexamethasone combination (4/42) when compared to the palonosetron group (0/42). The overall incidence of PONV was significantly higher in group I (23.81%: ondansetron and dexamethasone combination) than in group II (7.14%: palonosetron). The need for rescue medication in group I was significantly high. Conclusion: Palonosetron was more efficacious compared to the combination of ondansetron and dexamethasone for preventing PONV for laparoscopic gynaecological surgery.

Citing Articles

A Comparative Study on the Efficacy of Intravenous Palonosetron Versus a Combination of Ondansetron and Dexamethasone as Prophylaxis for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Surgeries.

Krishnan D, Asokan A, Muthalu A, Suganya S, Sujatha C Cureus. 2024; 16(10):e72214.

PMID: 39583456 PMC: 11584038. DOI: 10.7759/cureus.72214.


The intervention effect of psychological care combined with ondansetron, dexamethasone, and promethazine hydrochloride on chemotherapy in breast cancer surgical patients.

Li X, Dong L Technol Health Care. 2024; 32(6):5047-5063.

PMID: 39520157 PMC: 11613044. DOI: 10.3233/THC-240695.

References
1.
Candiotti K, Kovac A, Melson T, Clerici G, Gan T . A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg. 2008; 107(2):445-51. DOI: 10.1213/ane.0b013e31817b5ebb. View

2.
Gan T, Diemunsch P, Habib A, Kovac A, Kranke P, Meyer T . Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2013; 118(1):85-113. DOI: 10.1213/ANE.0000000000000002. View

3.
Li Y, Wei X, Zhang S, Zhou L, Zhang J . A Meta-Analysis of Palonosetron for the Prevention of Postoperative Nausea and Vomiting in Adults. J Perianesth Nurs. 2015; 30(5):398-405. DOI: 10.1016/j.jopan.2015.05.116. View

4.
Rojas C, Stathis M, Thomas A, Massuda E, Massuda E, Alt J . Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg. 2008; 107(2):469-78. DOI: 10.1213/ane.0b013e318172fa74. View

5.
Kim Y, Moon S, Song D, Lee K, Song J, Kwon Y . Comparison of palonosetron with ondansetron in prevention of postoperative nausea and vomiting in patients receiving intravenous patient-controlled analgesia after gynecological laparoscopic surgery. Korean J Anesthesiol. 2013; 64(2):122-6. PMC: 3581780. DOI: 10.4097/kjae.2013.64.2.122. View